
Tumor Marker Detections look for tumor markers, which are sometimes called cancer markers. Tumor markers are substances that are often made by cancer cells or by normal cells in response to cancer.
The global Tumor Marker Detection market is projected to reach US$ 38300 million in 2029, increasing from US$ 18900 million in 2022, with the CAGR of 12.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tumor Marker Detection 91ÖÆÆ¬³§.
In summary, the Tumor Marker Detection market is expanding due to the growing burden of cancer, advancements in diagnostic technologies, and the increasing need for personalized treatment approaches. The market is expected to continue growing as the understanding of cancer biology improves, leading to the discovery of novel tumor markers and the development of more targeted and effective cancer therapies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tumor Marker Detection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GRAIL
Exact Sciences
Lenco Diagnostic Laboratories, Inc.
AMADIX
Creative Biolabs
BGI
Segment by Type
Four Items of Tumor
Six Items of Tumor
Eight Items of Tumor
Full Set of Tumor Markers
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tumor Marker Detection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Marker Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Four Items of Tumor
1.2.3 Six Items of Tumor
1.2.4 Eight Items of Tumor
1.2.5 Full Set of Tumor Markers
1.3 Market by Application
1.3.1 Global Tumor Marker Detection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Marker Detection Market Perspective (2018-2029)
2.2 Tumor Marker Detection Growth Trends by Region
2.2.1 Global Tumor Marker Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tumor Marker Detection Historic Market Size by Region (2018-2023)
2.2.3 Tumor Marker Detection Forecasted Market Size by Region (2024-2029)
2.3 Tumor Marker Detection Market Dynamics
2.3.1 Tumor Marker Detection Industry Trends
2.3.2 Tumor Marker Detection Market Drivers
2.3.3 Tumor Marker Detection Market Challenges
2.3.4 Tumor Marker Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Marker Detection Players by Revenue
3.1.1 Global Top Tumor Marker Detection Players by Revenue (2018-2023)
3.1.2 Global Tumor Marker Detection Revenue Market Share by Players (2018-2023)
3.2 Global Tumor Marker Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tumor Marker Detection Revenue
3.4 Global Tumor Marker Detection Market Concentration Ratio
3.4.1 Global Tumor Marker Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Marker Detection Revenue in 2022
3.5 Tumor Marker Detection Key Players Head office and Area Served
3.6 Key Players Tumor Marker Detection Product Solution and Service
3.7 Date of Enter into Tumor Marker Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Marker Detection Breakdown Data by Type
4.1 Global Tumor Marker Detection Historic Market Size by Type (2018-2023)
4.2 Global Tumor Marker Detection Forecasted Market Size by Type (2024-2029)
5 Tumor Marker Detection Breakdown Data by Application
5.1 Global Tumor Marker Detection Historic Market Size by Application (2018-2023)
5.2 Global Tumor Marker Detection Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tumor Marker Detection Market Size (2018-2029)
6.2 North America Tumor Marker Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Tumor Marker Detection Market Size by Country (2018-2023)
6.4 North America Tumor Marker Detection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Marker Detection Market Size (2018-2029)
7.2 Europe Tumor Marker Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Tumor Marker Detection Market Size by Country (2018-2023)
7.4 Europe Tumor Marker Detection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Marker Detection Market Size (2018-2029)
8.2 Asia-Pacific Tumor Marker Detection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Tumor Marker Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific Tumor Marker Detection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Marker Detection Market Size (2018-2029)
9.2 Latin America Tumor Marker Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Tumor Marker Detection Market Size by Country (2018-2023)
9.4 Latin America Tumor Marker Detection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Marker Detection Market Size (2018-2029)
10.2 Middle East & Africa Tumor Marker Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Tumor Marker Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa Tumor Marker Detection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GRAIL
11.1.1 GRAIL Company Detail
11.1.2 GRAIL Business Overview
11.1.3 GRAIL Tumor Marker Detection Introduction
11.1.4 GRAIL Revenue in Tumor Marker Detection Business (2018-2023)
11.1.5 GRAIL Recent Development
11.2 Exact Sciences
11.2.1 Exact Sciences Company Detail
11.2.2 Exact Sciences Business Overview
11.2.3 Exact Sciences Tumor Marker Detection Introduction
11.2.4 Exact Sciences Revenue in Tumor Marker Detection Business (2018-2023)
11.2.5 Exact Sciences Recent Development
11.3 Lenco Diagnostic Laboratories, Inc.
11.3.1 Lenco Diagnostic Laboratories, Inc. Company Detail
11.3.2 Lenco Diagnostic Laboratories, Inc. Business Overview
11.3.3 Lenco Diagnostic Laboratories, Inc. Tumor Marker Detection Introduction
11.3.4 Lenco Diagnostic Laboratories, Inc. Revenue in Tumor Marker Detection Business (2018-2023)
11.3.5 Lenco Diagnostic Laboratories, Inc. Recent Development
11.4 AMADIX
11.4.1 AMADIX Company Detail
11.4.2 AMADIX Business Overview
11.4.3 AMADIX Tumor Marker Detection Introduction
11.4.4 AMADIX Revenue in Tumor Marker Detection Business (2018-2023)
11.4.5 AMADIX Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Detail
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs Tumor Marker Detection Introduction
11.5.4 Creative Biolabs Revenue in Tumor Marker Detection Business (2018-2023)
11.5.5 Creative Biolabs Recent Development
11.6 BGI
11.6.1 BGI Company Detail
11.6.2 BGI Business Overview
11.6.3 BGI Tumor Marker Detection Introduction
11.6.4 BGI Revenue in Tumor Marker Detection Business (2018-2023)
11.6.5 BGI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
GRAIL
Exact Sciences
Lenco Diagnostic Laboratories, Inc.
AMADIX
Creative Biolabs
BGI
Ìý
Ìý
*If Applicable.
